Medication info
Famoton 20mg (Famotidine)

Famoton 20mg (Famotidine)

Prescription medicationTabletOral · Intramuscular injection · Intravenous injection
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 1000 tablets/bottle
Approval status
Active

MFDS item code 202001905 · Approved 2020.03.18 · Insurance code 665002880

Summary

Main use
Treatment of gastrointestinal disorders (e.g., ulcers), preanesthetic medication, improvement of bleeding and gastric mucosal lesions
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or bleeding ulcer), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take 20mg of famotidine orally per dose twice daily (after breakfast and dinner or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injectable formulation; switch to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer 10mg of famotidine orally per dose twice daily (after breakfast and dinner or at bedtime), or 20mg orally once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine in 20ml of normal saline injection or glucose injection and administer by slow intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. In upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week; switch to oral administration once oral dosing is possible. When used as preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve it in 20ml of normal saline injection or glucose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (e.g., ulcers), preanesthetic medication, improvement of bleeding and gastric mucosal lesions

  • Gastric ulcers
  • duodenal ulcers
  • anastomotic ulcers
  • upper gastrointestinal hemorrhage
  • acute stress ulcers
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal erosion
  • gastric mucosal bleeding
  • gastric mucosal erythema
  • gastric mucosal edema
View approved original text

This medication is used for the treatment of various gastrointestinal diseases including gastric and duodenal ulcers. The oral formulation is particularly effective in treating gastric and duodenal ulcers, anastomotic ulcers, and peptic ulcers accompanied by gastric bleeding. It is also used for gastroesophageal reflux disease and Zollinger-Ellison syndrome to improve gastric mucosal lesions. It provides therapeutic assistance during acute exacerbations of acute and chronic gastritis. The injectable form is primarily used for severe hemorrhagic gastritis, acute stress ulcers, and pre-anesthesia medication. This drug helps to alleviate symptoms of gastrointestinal disorders and improves mucosal damage to support patient recovery.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcer, acute stress ulcer, or bleeding ulcer), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take 20mg of famotidine orally per dose twice daily (after breakfast and dinner or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injectable formulation; switch to oral administration once oral dosing is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Administer 10mg of famotidine orally per dose twice daily (after breakfast and dinner or at bedtime), or 20mg orally once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine in 20ml of normal saline injection or glucose injection and administer by slow intravenous injection twice daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip infusion. In upper gastrointestinal bleeding and Zollinger-Ellison syndrome, an effect is generally seen within 1 week; switch to oral administration once oral dosing is possible. When used as preanesthetic medication, dissolve 20mg in 1-1.5ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve it in 20ml of normal saline injection or glucose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours if stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients who have previously had an allergy to any of its components or other H2 receptor antagonists. Additionally, it should not be administered to patients with genetic lactose intolerance as it contains lactose. Caution is advised when administering to patients with a history of allergic reactions to medication, poor kidney function, heart disease, impaired liver function, and the elderly. In cases of impaired kidney function, the dose should be reduced or the administration interval extended. Patients with heart disease need to be aware of possible cardiovascular side effects. Observation is necessary for patients with poor liver function as symptoms may worsen. The elderly should use caution as they are at increased risk of decreased kidney function which may raise drug concentration. Rarely, serious allergic reactions, blood disorders, skin diseases, liver dysfunction, muscle damage, cardiac rhythm abnormalities, consciousness disorders, nephritis, pneumonia, and other side effects can occur. Should such symptoms appear, stop using the medication immediately and seek medical attention. Other uncommon side effects may include skin rashes, decreased blood cell counts, gastrointestinal symptoms, blood pressure changes, respiratory spasms, liver function abnormalities, neurological or psychiatric symptoms, and endocrine disorders. It is important to consult a physician if these symptoms occur. During treatment, symptoms, blood tests, and liver and kidney function tests should be monitored regularly, and if no effect is observed, it is advisable to switch to another treatment. The medication dissolves in the mouth but is not absorbed through the oral mucosa, so it must be swallowed with water. If a patient undergoing hemodialysis uses this medication in conjunction with phosphate binders, the effectiveness of some drugs may decrease. Caution is also warranted when combining this drug with certain antifungals or some chemotherapeutics as drug concentrations may decrease leading to reduced effectiveness. Women who are pregnant or may become pregnant should use this medication only when the benefits outweigh the risks, and nursing mothers are advised to discontinue breastfeeding as the drug can be transmitted through breast milk. Safety has not been adequately established in children, and its use is not recommended. Finally, this medication may mask the symptoms of gastric cancer, and should be used only after gastric cancer has been ruled out.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • generalized rash
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 89 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • generalized malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous syndrome
  • Reiter's syndrome
  • toxic epidermal necrolysis
  • liver function impairment
  • jaundice
  • increased AST
  • increased ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized seizures
  • tonic seizures
  • clonic seizures
  • myoclonic seizures
  • interstitial nephritis
  • acute renal failure
  • rash
  • urtication
  • abnormal renal function tests
  • interstitial pneumonia
  • high fever
  • cough
  • dyspnea
  • abnormal chest X-ray
  • decreased contractility
  • rash
  • urtication
  • urticaria
  • erythema
  • facial edema
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • melena
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • anorexia
  • stomatitis
  • elevated blood pressure
  • facial rash
  • tinnitus
  • bradycardia
  • tachycardia
  • AV block
  • bronchospasm
  • increased ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • generalized malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • sensory abnormalities
  • heavy feeling in the head
  • reversible confusional state
  • depression
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • increased CK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, and it is safest to keep it at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the medication's efficacy and prevent degradation.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 1000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.